37566 Federal Register / Vol. 65, No. 116 / Thursday, June 15, 2000 / Notices

Date and Time: The meeting will be

held on June 19, 2000, 10 a.m. to 6 p.m.

and on June 20, 2000, 10 a.m. to 4 p.m.

Location: Hilton, Salons A, B, and C,

620 Perry Pkwy., Gaithersburg, MD.

Contact Person: Megan Moynahan,

Center for Devices and Radiological

Health (HFZ–450), Food and Drug

Administration, 9200 Corporate Blvd.,

Rockville, MD 20850, 301–443–8517,

ext. 171, or FDA Advisory Committee

Information Line, 1–800–741–8138

(301–443–0572 in the Washington, DC

area), code 12625. Please call the

Information Line for up-to-date

information on this meeting.

Agenda: On June 19, 2000, the

committee will discuss, make

recommendations, and vote on a

premarket approval application for an

intravascular radiation device used in

the treatment of instent restenosis. On

June 20, 2000, the committee will

discuss a modification to the guidance

document entitled ‘‘Draft Guidance for

Implantable CardioverterDefibrillators.’’ Specifically, the

modification would allow general

indications for use for implantable

cardioverter defibrillators. The draft

guidance, version 4.3, issued June 24,

1996, is available to the public on the

Internet at http://www.fda.gov/cdrh/

ode/965.html. Background information,

questions for the panel, and a

bibliography for this topic will be

available to the public on the Internet at

http://www.fda.gov/cdrh/

panelmtg.html.

Procedure: On June 19, 2000, from 10

a.m. to 6 p.m. and on June 20, 2000,

from 10 a.m. to 4 p.m., the meeting is

open to the public. Interested persons

may present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by June 15, 2000. Oral

presentations from the public will be

scheduled between approximately 10

a.m. and 10:30 a.m., and near the end

of the panel deliberations on June 19,

2000, and between approximately 10

a.m. and 10:30 a.m., and near the end

of the panel deliberations on June 20,

2000. Time allotted for each

presentation may be limited. Those

desiring to make formal oral

presentations should notify the contact

person before June 12, 2000, and submit

a brief statement of the general nature of

the evidence or arguments they wish to

present, the names and addresses of

proposed participants, and an

indication of the approximate time

requested to make their presentation.

Closed Committee Deliberations: On

June 20, 2000, from 8 a.m. to 10 a.m.,

the meeting will be closed to permit

discussion and review of trade secret

and/or confidential commercial

information (5 U.S.C. 552b(c)(4)).

FDA regrets that it was unable to

publish this notice 15 days prior to the

Circulatory System Devices Panel of the

Medical Devices Advisory Committee

meeting. Because the agency believes

there is some urgency to bring these

issues to public discussion and

qualified members of the Circulatory

System Devices Panel of the Medical

Devices Advisory Committee were

available at this time, the Commissioner

of Food and Drugs concluded that it was

in the public interest to hold this

meeting even if there was not sufficient

time for the customary 15-day public

notice.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: June 9, 2000.

Linda A. Suydam,

Senior Associate Commissioner.

[FR Doc. 00–15204 Filed 6–13–00; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–643]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Collection

Request: Extension of a currently

approved request; Title of Information

Collection: Hospice Survey and

Deficiencies Report Form and

Supporting Regulations at 42 CFR

418.1–418.405; Form No.: HCFA–643

(OMB# 0938–0379); Use: In order to

participate in the Medicare program, a

hospice must meet certain Federal

health and safety conditions of

participation. This form will be used by

State surveyors to record data about a

hospice’s compliance with these

conditions of participation in order to

initiate the certification or

recertification process; Frequency:

Annually; Affected Public: State, local

or tribal government; Number of

Respondents: 2,293; Total Annual

Responses: 2,293; Total Annual Hours:

5,733.

To obtain copies of the supporting

statement and any related forms for the

proposed paperwork collections

referenced above, access HCFA’s Web

Site address at http://www.hcfa.gov/

regs/prdact95.htm, or E-mail your

request, including your address, phone

number, OMB number, and HCFA

document identifier, to

Paperwork@hcfa.gov, or call the Reports

Clearance Office on (410) 786–1326.

Written comments and

recommendations for the proposed

information collections must be mailed

within 30 days of this notice directly to

the OMB desk officer: OMB Human

Resources and Housing Branch,

Attention: Allison Eydt, New Executive

Office Building, Room 10235,

Washington, DC 20503.

Dated: May 30, 2000.

John P. Burke III,

HCFA Reports Clearance Officer, HCFA Office

of Information Services, Security and

Standards Group, Division of HCFA

Enterprise Standards.

[FR Doc. 00–15129 Filed 6–14–00; 8:45 am]

BILLING CODE 4120–03–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–668B]

Agency Information Collection

Activities: Submission for OMB

Review; Comment Request

AGENCY: Health Care Financing

Administration, HHS.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.